Skip to content

HOSPIPLAN: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HOSPIPLAN

BE 0459.516.615
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€205,799
2024 · €566,554-€772,353
Equity
€5.2m
2024 · €5.4m-€205,799
Cash
€271,809
2024 · €303,564-€31,755
Balance sheet total
€5.3m
2024 · €5.6m-€285,841

Largest movements

2024 to 2025
Assets
  • Financial fixed assets -€257,389

    down €257,389 (-6.0%), from €4.3m to €4.1m

Equity and liabilities
  • Profit (loss) carried forward -€205,799

    down €205,799 (-15.2%), from -€1.4m to -€1.6m

Income statement
  • Financial income -€496,226

    down €496,226 (-99.5%), from €498,767 to €2,541

    of which Non-recurring financial income: -€497,553

  • Financial charges +€257,193

    up €257,193 (+41513.6%), from €620 to €257,813

    of which Non-recurring financial charges: +€257,389

  • Gross operating margin -€44,208

    down €44,208 (-46.7%), from €94,701 to €50,493

  • Taxes -€25,235

    no longer reported in 2025 (was €25,235)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €566,554
Gross operating margin -€44,208
Other operating charges +€40
Financial income -€496,226
Financial charges -€257,193
Taxes +€25,235
Result 2025 -€205,799

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€287,361
Investment +€255,606
Financing €0
Cash 2024 €303,564
Net result for the year -€205,799
Stocks and contracts -€10,264
Receivables within one year +€8,744
Deferred charges and accrued income +€0
Trade debts -€55,305
Tax, wage and social debts -€24,736
Investment in fixed assets (net) +€257,389
Current investments -€1,783
Cash 2025 €271,809
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,573,448 €5,287,607 -€285,841 -5.1%
Fixed assets 21/28 €4,323,207 €4,065,818 -€257,389 -6.0%
Financial fixed assets 28 €4,323,207 €4,065,818 -€257,389 -6.0%
Current assets 29/58 €1,250,241 €1,221,790 -€28,452 -2.3%
Stocks and contracts in progress 3 €85,603 €95,867 +€10,264 +12.0%
Stocks 30/36 €85,603 €95,867 +€10,264 +12.0%
Amounts receivable within one year 40/41 €709,834 €701,090 -€8,744 -1.2%
Trade receivables 40 €330,102 €279,811 -€50,291 -15.2%
Other amounts receivable 41 €379,733 €421,279 +€41,547 +10.9%
Current investments 50/53 €150,926 €152,710 +€1,783 +1.2%
Cash at bank and in hand 54/58 €303,564 €271,809 -€31,755 -10.5%
Deferred charges and accrued income 490/1 €314 €314 -€0 0.0%
Total equity and liabilities 10/49 €5,573,448 €5,287,607 -€285,841 -5.1%
Equity 10/15 €5,415,687 €5,209,887 -€205,799 -3.8%
Contributions 10/11 €6,515,250 €6,515,250 = 0.0%
Reserves 13 €250,693 €250,693 = 0.0%
Distributable reserves 133 €250,693 €250,693 = 0.0%
Profit (loss) carried forward 14 -€1,350,257 -€1,556,056 -€205,799 -15.2%
Amounts payable 17/49 €157,761 €77,720 -€80,041 -50.7%
Amounts payable within one year 42/48 €157,761 €77,720 -€80,041 -50.7%
Trade debts 44 €125,841 €70,536 -€55,305 -43.9%
Suppliers 440/4 €125,841 €70,536 -€55,305 -43.9%
Taxes, remuneration and social security 45 €31,920 €7,184 -€24,736 -77.5%
Taxes 450/3 €31,920 €7,184 -€24,736 -77.5%
Other operating charges 640/8 €1,060 €1,020 -€40 -3.8%
Gross operating margin 9900 €94,701 €50,493 -€44,208 -46.7%
Operating profit (loss) 9901 €93,642 €49,473 -€44,169 -47.2%
Financial income 75/76B €498,767 €2,541 -€496,226 -99.5%
Recurring financial income 75 €1,214 €2,541 +€1,327 +109.3%
Non-recurring financial income 76B €497,553 - -€497,553
Financial charges 65/66B €620 €257,813 +€257,193 +41513.6%
Recurring financial charges 65 €620 €424 -€196 -31.6%
Non-recurring financial charges 66B - €257,389 +€257,389
Profit (loss) for the period before taxes 9903 €591,789 -€205,799 -€797,588
Income taxes 67/77 €25,235 - -€25,235
Profit (loss) for the period 9904 €566,554 -€205,799 -€772,353
Profit (loss) for the period to be appropriated 9905 €566,554 -€205,799 -€772,353

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.